Ron Cohen, Andrew R Blight. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » 4-Aminopyridine/economics4-Aminopyridine/therapeutic useDelayed-Action PreparationsDrug ApprovalDrug CostsDrug Discovery/economicsDrug Discovery/statistics & numerical dataHumansMultiple Sclerosis/drug therapyMultiple Sclerosis/economicsPotassium Channel Blockers/economicsPotassium Channel Blockers/therapeutic useResearch Design/standardsTime FactorsUnited States
Substances： See more » Delayed-Action PreparationsPotassium Channel Blockers4-Aminopyridine
Year: 2011 PMID： 21280101 DOI： 10.1002/ana.22322
Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422